| | Variables | r | P value |
| | Age (years) | 0.407 | <0.001 | | Female, n (%) | −0.181 | <0.001 | | Current smoking, n (%) | −0.151 | <0.001 | | BMI (kg/m2) | −0.235 | <0.001 | | eGFR (ml min −1 1.73 m2) | −0.125 | 0.001 | | 0 h PG (mmol/L) | 0.052 | 0.158 | | 2 h PG (mmol/L) | 0.001 | 0.988 | | Δ PG (mmol/L) | −0.016 | 0.675 | | 0 h C-peptide (ng/ml) | −0.043 | 0.249 | | 2 h C-peptide (ng/ml) | 0.086 | 0.020 | | Δ C-peptide (ng/ml) | 0.115 | 0.002 | | HbA1c (%) | 0.077 | 0.037 | | TC (mmol/L) | 0.065 | 0.079 | | TG (mmol/L) | −0.100 | 0.007 | | HDL-C (mmol/L) | 0.158 | <0.001 | | LDL-C (mmol/L) | 0.029 | 0.435 | | Heart rate (beats/min) | 0.025 | 0.497 | | Mean 24 h SBP (mmHg) | 0.211 | <0.001 | | Mean 24 h DBP (mm Hg) | −0.015 | 0.678 | | Stable angina, n (%) | 0.081 | 0.029 | | Calcium channel blocker, n (%) | 0.160 | <0.001 | | ACEI, n (%) | 0.009 | 0.805 | | ARB, n (%) | 0.062 | 0.095 | | β-Blocker, n (%) | 0.032 | 0.386 | | Diuretic, n (%) | 0.167 | <0.001 | | α-Blocker, n (%) | 0.012 | 0.751 | | Statins use, n (%) | 0.178 | <0.001 |
|
|
baPWV, brachial-ankle pulse wave velocity; BMI, body mass index; eGFR, estimated glomerular filtration rate; PG, plasma glucose; HbA1c, hemoglobin A1c; TC, total cholesterol; TG, triglycerides; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein; SBP, systolic blood pressure; DBP, diastolic blood pressure; ACEI, angiotensin-converting enzyme inhibitor; ARB, angiotensin-converting enzyme receptor blocker.
|
